Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trialResearch in context

• Main Authors: Mattia Boeri (Author), Federica Sabia (Author), Roberta E. Ledda (Author), Maurizio Balbi (Author), Paola Suatoni (Author), Miriam Segale (Author), Anna Zanghì (Author), Anna Cantarutti (Author), Luigi Rolli (Author), Camilla Valsecchi (Author), Giovanni Corrao (Author), Alfonso Marchianò (Author), Ugo Pastorino (Author), Gabriella Sozzi (Author)
• Format: Book
• Published: Elsevier, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: The proper management of suspicious radiologic findings is crucial to optimize the effectiveness of low-dose computed tomography (LDCT) lung cancer screening trials. In the BioMILD study, we evaluated the utility of combining a plasma 24-microRNA signature classifier (MSC) and L...